A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
2 April 2024
Following the postponement of an in-person EMC2020 due to the pandemic, we’re delighted that EMC2024 is taking place from Sunday 25th August to Friday 30th August 2024 in Copenhagen. EMC2024 is the 17th of its kind and will bring the world of scientific imaging together in one of Europe’s most beautiful cities - Copenhagen, Denmark.
24 January 2024
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
20 December 2023
IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
20 December 2023
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
24 September 2023
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
24 September 2023
Unlock the power of interoperability and scalability with the NanoZoomer S20 digital slide scanner, C16300-01 – the ultimate solution for your lab's evolving needs. Our focus is on providing you with a seamless experience, tailored to fit your unique workflow, regardless of the size or scope of your laboratory.
Product Profile, 28 February 2024
Leica Microsystems, a world leader in microscopy and scientific instrumentation, has launched an evolved version of its ARveo 8 digital visualization microscope for neurosurgery.
Product Profile, 29 January 2024
Cherwell, cleanroom microbiology solutions expert, has launched the Redipor® Beta Bag to ensure the safe transfer of ready-to-use gamma-irradiated prepared media into sterile manufacturing environments. This new multiple-use product transfer bag can reduce risk, cost and time in environmental monitoring (EM) processes during continuous manufacturing of sterile medicinal products.
Product Profile, 29 January 2024
LASER COMPONENTS is pleased to offer the TENOR-2000 from Cybel which is a wavelength tunable PM fibre laser. It has a broadband wavelength tuning range of 1900 to 2050nm and is available with >1W output power.
Product Profile, 16 January 2024'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Product Profile, 24 September 2023
SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, is pleased to announce a partnership with BioLabs, the global innovation support platform.
Press Releases, 22 April 2024
Today, family-run community pharmacy chain Jardines Pharmacy (“Jardines”), primarily based in Milton Keynes and Bedfordshire, announces the launch of the Jardines Pharmacy app in collaboration with Charac, the UK’s premier patient relationship management platform for pharmacies. Charac’s platform will help Jardines digitalise its services, improving operational effectiveness and customer satisfaction.
Press Releases, 21 April 2024
Regeneron Pharmaceuticals, Inc today announced that new and updated data across its genetic medicines portfolio will be presented at the American Society of Gene and Cell Therapy (ASGCT) annual conference in Baltimore, Maryland, from May 7 to 11, 2024.
Press Releases, 21 April 2024
The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, today entered into a partnership with SRG, leaders in life science recruitment, to support the advancement of science professionals in their careers.
Press Releases, 15 April 2024A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
Press Releases, 2 April 2024
While still in its infancy, it is estimated that both AR and VR will surpass 100 million users worldwide by 2027. In realising this trend, it is clear that organisations adopting AR/VR app development services to create immersive experiences for their users which may enable them to excel within the realm of healthcare
Digital, 20 December 2023
Ensuring a robust foundation of performance metrics to underpin a strategy is key to navigating the challenges and getting fit for growth. However, amid firefighting to overcome day-to-day challenges, knowing where to start in setting key performance indicators and finding the right ways to track, measure and analyse them to glean actionable insights can often be a minefield that is easily sidelined
Digital, 20 December 2023
In the UK, one in 50 adults is living with a chronic wound, leading to more than £8bn in healthcare costs in 2017/2018. However, these numbers are likely to be higher since the pandemic as a result of reduced care in 2020 and 2021, impacting patient outcomes. With a growing ageing population and the increasing prevalence of people with comorbidities, these costs are likely to continue to rise until new solutions can be implemented to improve current standard care and control
Digital, 20 December 2023
An exploration of the thoughts on the significance of generative AI within life sciences and pharma
Digital, 24 September 2023
What Pharma 4.0 looks like, the strategic role that a laboratory information management system plays and the presentation of a case study that underscores the power of a well-aligned digital strategy to catalyse innovation within organisations
Digital, 24 September 2023
This article explores the significant opportunities within the biologics contract development and manufacturing organisation (CDMO) industry to optimize client satisfaction by meeting the critical demands of discerning clients. Six key facets are identified as pivotal to success, while underscoring the fundamental role of a client-centric approach and the importance of building and nurturing strong client relationships.
Robots are revolutionising manufacturing, but manual programming hampers their potential. Robot offline programming offers a digital solution, reducing human work hours by up to 80% and ensuring swift task readiness
In the post-covid-19 era, healthcare grapples with staff shortages and treatment delays, emphasising the need for early diagnosis. While regulatory changes pose challenges, eu extensions provide relief
Proteins govern crucial biological processes, making protein-protein interactions vital for understanding and treating diseases, peptide-based mimics offer tailored therapeutic approaches, yet optimising their efficacy poses challenges
After assessing the various routes of drug administration, oral delivery stands out as the safest and, as a result, the most universally accepted among patients. Single-unit dosage forms, including tablets followed by capsules, have been identified as the preferred designs for immediate or modified release formulations
Drug administration by inhalation is an established technique for treating respiratory and systemic diseases. Effective drug delivery to the lungs requires the aerosolisation and dispersion of a formulation into particles or droplets in the inhalable size range, typically an aerodynamic diameter below 5 µm. In many cases, particle engineering is used to optimise a formulation for efficacy
Refeyn discusses the challenges associated with AAV manufacture, the key analytical techniques currently used to facilitate insight into AAV samples and novel techniques striving to overcome current limitations
By seamlessly integrating a dynamic MES into digitisation road maps, companies have achieved greater operational efficiency, data integrity and harnessed real-time insights to meet their strategic goals
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
While the drug-device combination product industry is always investing in technology that could better meet the needs of patients, governments and sponsors, the COVID-19 pandemic has accelerated the process, bringing in more outside investment and a broader range of organisations in active development
What are some trends in the mRNA space surrounding the growing desire for speed-to-market, and what hurdles are impeding the achievement of this goal?
Drug product optimisation, also known as reformulation, is a development step required by all drugs en route to market. This process takes a long time, carries a considerable cost and places significant emphasis on the predictive power of laboratory and preclinical assessments. What are some alternative pathways available to development teams?
For different binder-diluent ratios on the tablet mechanical strength, a proposed scale could serve as a ‘guiding torch’ for various formulators while designing preclinical or early phase formulations
High-titre CLD platform is an effective tool to overcome a number of challenges when developing a cell line. What are the challenges associated with developing a high-titre CLD platform and how can utilising novel technologies help overcome them?
Nanodrug carriers have gained increased attention in the pharma industry since they were used in the fight against COVID-19. What are they, and how can regulations improve the manufacture of them?
What are the differences and key design features which characterise successful tablet press performance in a continuous manufacturing setting?
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations
Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades
The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
The development and use of novel gene therapy approaches is increasing. With the advent of innovative technologies using improved tropism and safer viral-based systems, and nanotechnology advancing non-viral delivery of nucleic acid vectors, there will be more gene-based products entering the market in near future
Discovery and Development, 18 March 2024
Ipt talks with jacob tesdorpf at revvity about the recent developments in preclinical imaging, from ai-enchanced analysis to refined disease models
Discovery and Development, 18 March 2024
The World Health Organization (WHO) has recognised the scarcity of new antimicrobial agents in the clinical pipeline. The prevailing approach to combatting antimicrobial resistance cannot solely rely on developing new drugs. Instead, we must seek ways to better understand and more efficiently use the drugs already at our disposal.
Discovery and Development, 20 December 2023
IPT talks to Oliver Rinner of Biognosys about Bruker’s recent majority investment in the business and how this, along with its own developments, will affect the future of proteomics research
Discovery and Development, 24 September 2023
With its potential to transform various industries and fields of research − including pharmaceuticals, preventive healthcare, agriculture and food safety − metabolomics is a rapidly growing field that has the potential to revolutionise our understanding of biological systems and disease mechanisms
Discovery and Development, 24 September 2023
Thermo fisher scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production
Analytics, 18 March 2024
Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years
Analytics, 18 March 2024IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
Analytics, 20 December 2023
IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future
Analytics, 20 December 2023
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
Analytics, 24 September 2023
Www.mmc-series.org.uk
Analytics, 24 September 2023
Automate 2024 consists of the 3rd Annual SmartLabs Automation & Robotics Congress, at which visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the pharma automation industry in the future. Join leaders, experts and researchers and discuss digital QA/QC labs, accelerating digital transformation, lab robotics & tools for drug discovery workflows, robotic process automation and implementing AI/ML in the lab.
Conferences and Events , 6 March 2024
North America’s senior leaders across marketing, commercial, patient engagement, medical affairs, market access, and for the first time, cell and gene therapy, will gather to forge pharma’s new identity and spark healthcare’s revolution. Taking place in Philadelphia March 28-29th, this industry-defining meeting will return better than ever as we have a larger venue, 1200+ attendees, 100+ speakers, 40+ in-depth case studies and exclusive networking opportunities.
Conferences and Events , 26 February 2024
Pharma’s role within the healthcare system is weakening. Increased demand, economic strains, suffocating regulatory change and a widening access gap is impacting future pipelines and commercial innovations reaching patients. Siloed functions too often compete with each other instead of complement each other, failing to rally behind a common purpose.
Conferences and Events , 26 February 2024
Ahead of its highly anticipated 2024 edition, LogiPharma, the world’s largest life sciences supply chain event, has revealed more details about how guests can tailor their experience across a variety of important industry topics. Due to take place in Lyon, France this 16-18th April, the three-day conference will feature six distinct tracks each occupying a dedicated room.
Conferences and Events , 8 February 2024
With a current capacity of over 1.3 million tonnes for CO2-based products and steadily growing demand, smart Carbon Capture and Utilisation (CCU) technologies are helping to establish CO2 as a renewable carbon feedstock. Innovative technologies and materials are crucial to meet the increasing demand for fossil-free carbon, e.g. derived from CO2 or biomass, especially in the chemical and fuel sector. Having established itself as a cornerstone in the evolution
Conferences and Events , 7 February 2024
Next Ilmac in Lausanne: 18 and 19 September 2024 | Beaulieu Lausanne Next Ilmac in Basel: 16 - 18 September 2025 | Messe Basel, Hall 1.0 All information at: www.ilmac.ch
IPT TV, 16 April 2024
INTERPHEX, the premier pharmaceutical and biotechnology event taking place April 16-18, 2024, at the Javits Center in NYC, is proud to introduce INTERPHEX Conference, an all-new, transformative event that will enrich the meeting experience for attendees, starting in 2024.
IPT TV, 9 April 2024
Book your 𝗙𝗥𝗘𝗘 𝗩𝗜𝗦𝗜𝗧𝗢𝗥 𝗣𝗔𝗦𝗦 for the UK’s most important biotechnology tradeshow and conference today and join thousands of industry professionals from across the globe. Don't miss your chance to explore the groundbreaking advancements in medical & healthcare sectors and be a part of the global biotechnology revolution.
IPT TV, 7 March 2024Following the postponement of an in-person EMC2020 due to the pandemic, we’re delighted that EMC2024 is taking place from Sunday 25th August to Friday 30th August 2024 in Copenhagen. EMC2024 is the 17th of its kind and will bring the world of scientific imaging together in one of Europe’s most beautiful cities - Copenhagen, Denmark.
IPT TV, 24 January 2024
24 August 2023 -- IPT TV -- Ilmac takes place next month 26-28th September in Basel.
IPT TV, 23 August 2023
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
